Overview

Safety and Efficacy Study in Acute Ischaemic Stroke

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
Phase:
Phase 2
Details
Lead Sponsor:
Vernalis (R&D) Ltd